Product Wiki · Recalls · EU Safety Gate (RAPEX)

10-OH-HHC Vape Pen - — recall SR/02515/25

EU Safety Gate (RAPEX) · Germany · 2025-07-11 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/02515/25
Date of alert
2025-07-11
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
Highappy
Product category
Chemical products
Product type
Disposable electronic cigarette
Barcode (EAN/GTIN)
4262442290630
Reported risk: Laut Kennzeichnung enthält das Produkt das psychoaktive Cannabinoid 10-OH-HHC. Diese Substanz kann psychische und Verhaltensstörungen verursachen. Das Produkt entspricht nicht den Anforderungen der Tabakproduktrichtlinie.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Removal of this product listing by the online marketplace
Date of entry into force
12/06/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): 10-OH-HHC Vape Pen -

Risk Description (original English): According to the labelling, the product contains the psychoactive cannabinoid 10-OH-HHC. This substance can cause mental and behavioural disorders.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10095129

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.